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Summary 
Neocarazostatin A (NZS) is a bacterial alkaloid with promising bioactivities against free 
radicals, featuring a tricyclic carbazole nucleus with a prenyl moiety at C-6 of the carbazole 
ring. Herein we report the discovery and characterization of the biosynthetic pathway of NZS 
through genome mining and gene inactivation. The in vitro assays characterized two enzymes: 
NzsA is a P450 hydroxylase and NzsG is a new phytoene-synthase-like prenyltransferase 
(PTase). This is the first reported native PTase that specifically acts on carbazole nucleus. 
Finally, our in vitro reconstituted experiment demonstrated a coupled reaction catalysed by 





Carbazoles consist of a tricyclic nucleus with two benzene rings flanking a pyrrole ring. Most 
of the known naturally occurring carbazole alkaloids contain an annulated ring or ring system 
in both benzene rings and were isolated from higher plants and fungi, which display a broad 
range of biological properties such as anticancer, antibacterial, antiviral, and antiplasmodial 
activities (Knölker and Reddy, 2002). To date, the biosynthesis of plant carbazole metabolites 
is not fully understood (Schmidt, et al., 2012). The most widely accepted hypothesis is that 
the nucleus of carbazole alkaloids from higher plants may derive from anthranilic acids and 
prenyl pyrophosphate (Schmidt, et al., 2012).  
In contrast to widespread carbazole alkaloids from higher plants and fungi, bacterial carbazole 
metabolites are much less common. The first class of bacterial carbazoles are indolo[2,3-
a]pyrrolo[3,4-c] carbazoles, representatives of which include staurosporine (Meksuriyen, et 
al., 1988) and rebeccamycin (Pearce et al., 1988), and the second class are 
indolosesequiterpenes, representatives of which are oridamycins (Takada, et al., 2010) and 
xiamycins (Ding, et al., 2010; Ding, et al., 2011). The bio-origins of both types of carbazole-
containing metabolites have been well-established in the last decade (Howard-Jones et al., 
2006; Xu, et al, 2012; Li et al. 2012; Li et al., 2015 and Baunach et al., 2015). The third type of 
carbazoles, however, consist of a simple tricyclic ring system with aliphatic side chains, 
including carquinostatins, carazostatin, carbazoquinocins, carbazomycin, (S)-streptoverticillin 
and neocarazostatins (Feng, et al., 2007; Kato, et al., 1989; Kato, et al., 1991; Ruanpanun, et 
al., 2011; Sakano and Nakamura, 1980; Shin-ya, et al., 1993; Shin-ya, et al., 1997; Tanaka, et 
al., 1995) (Figure 1). Generally this group of bacterial carbazoles can act as free radical 
scavengers and exhibit potent neuronal cell protecting activity (Schmidt, et al., 2012). Free 
radicals play a key role in the initiation of a variety of diseases such as cerebral and myocardial 
ischemia, arteriosclerosis, inflammation, rheumatism and cancer. Antioxidants, acting as free 
radical scavengers, can act as protecting substances against damage caused by free radicals 
(Palinski, et al., 1989). In this respect, free radical scavenging compounds are being 
extensively investigated as potential drug leads (Schmidt, et al., 2012). Due to their 
pharmacological potential as cell protecting agents, there has been considerable interest for 
medicinal chemists to develop this class of molecules (Choshi, et al., 1997; Czerwonka, et al., 
2006; Rawat and Wulff, 2004; Shin and Ogasawara, 1996). The biosynthetic pathways of this 
group of bacterial carbazoles have not been reported although feeding experiments 
confirmed that L-tryptophan, pyruvate and acetate provide the carbazole nucleus (Kaneda, et 
al., 1990; Orihara, et al., 1997; Yamasaki, et al., 1983) (Figure S1A). 
In our screening programme to discover novel natural products from the soil bacterium 
Streptomyces sp. MA37 (Deng, et al., 2014; Huang, et al., 2015; Ma, et al., 2015), 
neocarazostatin A 1 was isolated from this strain (Figure S1B-1G). Neocarazostatins A-C 
(Figure 1) were originally discovered from the culture of Streptomyces sp GP38 in 1991 (Kato, 
et al., 1991). The neocarazostatins exhibited a strong inhibition effect on the free radical 
induced lipid peroxidation in rat brain homogenate. The IC50 values of the neocarazostatins 
for inhibition of lipid peroxidation were considerably lower than those of the free radical 
scavenger butylhydroxytoluene (BHT) and brain protective agent flunarizine (Kato, et al., 
1991). 
In this study, we report the actinobacterial biosynthetic gene cluster for the biosynthesis of 
NZS. Two enzymes, NzsA and NzsG, were biochemically characterized. NzsA is a P450 
hydroxylase and NzsG is a phytoene-synthase-like (PSL) prenyltransferase, a PSL protein that 
catalyses the prenylation of carbazole. Finally we reconstituted in vitro the last two steps of 
the pathway to NZS using purified recombinant enzymes. 
Results and Discussion 
Identification of the nzs gene cluster 
NZS 1 possesses a prenyl group at C-6 on the indole ring. Initially, a homolog search of 
bacterial indole prenyltransferases was conducted. IptA from Streptomyces sp. SN-593 has 
been shown to be a 6-dimethyl-allyl (DMAL)-L-tryptophan synthase which is involved in the 
biosynthesis of 6-DMAL-3-carbaldehyde (Takahashi, et al., 2010). Although IptA homologs 
appeared to be widely spread in the Streptomyces genome, to our surprise, a BLAST search of 
the annotated genome of MA37 in the RAST server(Aziz, et al., 2008) yielded no ORFs with 
any obvious sequence identity to IptA in MA37. 
Previous labelling studies established that indole pyruvate originating from L-tryptophan is 
likely to contribute rings B and C plus the intact C2 unit of C-3 and C-4 of ring A in the 
biosynthesis of carquinostatin B 3b (Figure S1A)(Kato, et al., 1991), a structurally close 
analogue of 1 (Figure 1). The incorporation of pyruvate in secondary metabolism can also be 
observed in the biosynthesis of sugars containing a two-carbon branched chain, such as 
antibiotic natural products, yersiniose A from the Gram-negative bacterium Yersinia 
pseudotuberculosis, (Chen, et al., 1998) aldgamycin E from Saccharothrix SA 103 (Ellestad, et 
al., 1967) and presumably tianchimycin B from Saccharothrix xinjiangensis. (Wang, et al., 
2013). An in vitro assay indicated that the gene product YerE is a thiamine pyrophosphate 
(ThDP)-dependent enzyme, responsible for the C-C bond formation between 3-ketosugar and 
pyruvate during the biosynthesis of yesiniose A (Chen, et al., 1998; Lehwald, et al., 2010). We 
performed a homolog search of YerE in MA37, resulting in identification of an ORF, annotated 
as a ThDP-dependent enzyme (NzsH) (Figure 2A and Table 1), which shows moderate 
sequence identity (27%) to YerE.  
Analysis of the genesin the close proximity of nzsH allowed us to retrieve a candidate gene 
cluster (nzs) spanning approximately 17.8 kb (Figure 2A and Table 1). The nzs cluster possesses 
10 ORFs, 9 of which (NzsA-H and J) can be assigned catalytic functions (Table 1). A BLAST 
search of NzsI indicated that it belongs to a small group of hypothetical proteins with no 
obvious catalytic function. Genes beyond this region are highly conserved in the 
chromosomes of other non-NZS producing Streptomyces strains such as S. griseus, S. 
avermitilis, and S. coelicolor (Figure S2A). Thus, we propose that these 10 orfs define the 
boundaries of the nzs cluster. 
 
In vivo experiments confirmed that the candidate gene cluster directs the biosynthesis of 
NZS 1 
To confirm the identity of the nzs cluster, gene disruption was performed and 10 different 
mutants (ΔnzsA-J) were generated (Figure S2B-2L). HPLC analysis of the extracts from these 
mutants demonstrated that inactivation of nzsE-F and nzsH-J completely abolished the NZS 
production (Figure 2B), suggesting that these five ORFs are essential for the biosynthesis of 1. 
Inactivation of nzsB-D, encoding anthranilate phosphoribosyltransferase, isopentenyl 
diphosphate (IPP) isomerase, and aromatic aminotransferase, respectively, resulted in only 
slightly decreased production of 1 (Figure 2B 5-8). In accordance with these findings, 
bioinformatics analyses of the draft genome sequence of the MA37 revealed the presence of 
several other gene copies with predicted functions similar to NzsB-D, suggesting the cross-
complementation roles played by these genes.  
Gene disruption of nzsG completely abolished the production of 1 but resulted in 
accumulation of two new metabolites in the culture of the ΔnzsG mutant (Figure 2B 4). 
Subsequently fermentation and chemical isolation afforded two pure compounds, 4 (7 mg) 
and 5 (4.3 mg) (Figure 3). The structures of 4 and 5 were established by the inspection of HR-
ESIMS and 1-D and 2-D NMR spectral data and by comparison of the NMR spectral data with 
those of 1 (Tables S4-5 , Figure S3A-3F and Figure S3M-3R). Although compound 4 has 
identical chemical shifts in NMR spectra to the known carbazole metabolite, (S)-
streptoverticillin, comparison of the values of the optical rotation of 4 with the ones of (S)-
streptoverticillin and its non-natural enantiomer (R)-streptoverticillin (Thomas et al. 2011) 
indicated that 4 actually is (R)-streptoverticillin. Compound 5 is a new carbazole intermediate, 
which was named as precarazostatin. Both 4 and 5 lack prenyl substitution at C-6, suggesting 
that NzsG may be responsible for the prenylation at C-6 of the carbazole nucleus. 
HPLC analysis also showed that, while the production of 1 was lost in the culture of the ΔnzsA 
mutant, two new metabolites, 2 and 6, were accumulated (Figure 2B 2). Fermentation and 
isolation, followed by analyses of HR-ESIMS and 1-D and 2-D NMR spectral and optical 
rotation data established that one metabolite is a known carbazole metabolite, 
neocarazostatin B 2 (Figure 3, Figure S3G-3R)a close derivative of 1, suggesting that NzsA may 
be responsible for the installation of the hydroxyl group at C-11 of 2 to generate 1. The 
structure of compound 6 was determined as a new epoxy derivative of 2 on the basis of HR-
ESIMS and 1- and 2-D NMR analyses, which clearly indicated the replacement of Δ16,17 in 2 
with an epoxy ring (Figure 3 and Figure S3S-3X). 
Biochemical assay demonstrated that NzsG is a new prenyltransferase that specifically acts 
on 5 
Given that 4 and 5 are not further metabolised in the ΔnzsG mutant, it was envisaged that 
they may be immediate substrates of NzsG. Bioinformatics analysis revealed that NzsG shares 
high sequence identity (60-65%) with only three hypothetical proteins from Streptomyces but 
has 25-40% similarity to a large family of putative phytoene synthases from actinomycetes. It 
also possesses a characteristic DDxxD motif which is essential for binding prenyl diphosphate 
via metal ions (Liang, et al., 2002). However, NzsG shows no homology to the identified 
bacterial or fungi aromatic or indole PTases. Further phylogenetic analysis indicated that NzsG 
forms the same branch with phytoene synthases instead of all of the known aromatic or 
indole PTases (Figure S4A), implying that NzsG may be a new type of emerging PTase family. 
To determine the exact function of NzsG, we carried out a biochemical study. Over-expression 
of nzsG in E. coli allowed isolation and purification of its encoded protein. The resultant NzsG 
appeared on SDS-PAGE with an estimated mol wt of 38.1 kDa (Figure S4B). Incubations of the 
recombinant enzyme with dimethylallyl pyrophosphate (DMAPP) and 4 or 5, supplemented 
with Mg2+ (5 mM), were performed and the reactions were monitored by HPLC. When the 
assays were conducted in the absence of DMAPP or in the presence of 4, there was no 
turnover (Figure 4). Reactions with 5, however, resulted in an efficient conversion of 5 to 
neocarazostatin B 2 as evidenced by the exact mass and co-elution time with the authentic 
sample of 2 (Figure 4A-B and Figure S4C), confirming that 5 is the key intermediate in the NZS 
biosynthesis but its bis-methylated derivative, 4, is a shunt product in the ΔnzsG mutant 
(Figure 4). The enzyme was found to have optimal activity at pH 8.0 at 30 oC in presence of 
Mg2+ (5mM)(Km (5) = 202.5 ± 35.40, kcat = 0.052 ± 0.004 min-1) (Figure S4D-4F). There was no 
turnover when NzsG was incubated with DMAPP or FPP or indol derivatives (e.g. L-
tryptophan, indole 3-pyruvate) or other tricyclic molecules (e.g. carbazole, acridine, fluorene, 
phenazine and dibenzothiophene, Figure 4 and Figure S4G-4H), suggesting that NzsG has 
restricted substrate specificity. It has been demonstrated that some fungal indol PTases 
possess substrate promiscuity and can be used to prenylate larger aromatic ring systems, i.e. 
indolocarbazoles, using chemoenzymatic approach (Yu, et al., 2012). NzsG, however, is the 
first native carbazole PTase reported and belongs to a new subgroup of aromatic PTases. 
Biochemical assay demonstrated that NzsA is a P450 hydroxylase enzyme 
Overexpression of nzsA in E. coli allowed isolation and purification of a soluble protein with 
an estimated mol wt 46.0 kDa, as observed in SDS-PAGE (Figure S5A). CO binding assay on 
NzsA monitored by UV spectroscopy demonstrated that NzsA is indeed a P450 enzyme (Figure 
S5B) (Meunier, et al., 2004). In vitro experiments showed that the recombinant enzyme 
efficiently converted 2 into 1 (Figure S5C) in the presence of NADPH (see supporting 
information). In control experiments, when assays were conducted in the absence of the 
NADPH or the enzyme NzsA or in the presence of 6, there were no turnovers (Figure 5), 
confirming that NzsA catalyses the installation of the hydroxyl group at C-11 position of 2 to 
yield 1 and the epoxy derivative 6 is a shunt product in the ΔnzsA mutant. NzsA was also 
incubated with (R)-streptoverticillin 4 and precarazostatin 5, but in both cases, no formation 
of a new product, or disappearance of the starting material, was observed (Figure 5). These 
observations strongly suggest that NzsA mediates the last enzymatic step in the biosynthesis 
of 1. 
To further confirm the biotransformation from 5 to 1 in the NZS biosynthesis, in vitro 
reconstituted biotransformation was carried out. Upon the incubation of 5 with the 
recombinant enzymes, NzsG and A, along with DMAPP, Mg2+, and NADPH (see the supporting 
information), we observed the formation of 1 and 2 as evidenced by the exact mass and the 
same HPLC retention time as the authentic 1 and 2 (Figure S5D-5E).  
Discussion 
Based on the bioinformatics analysis and the experimental data, we propose the biosynthetic 
pathway of 1 in MA37 as shown in Scheme 1. NzsB-F are likely to be involved in the precursor 
pathways. NzsB could be a housekeeping enzyme for tryptophan supply. NzsD resembles a 
family of PLP-dependent aromatic amino acid aminotransferases, suggesting its role in the 
conversion of L-tryptophan to indole-3-pyruvic acid. NzsC, a putative type I isopentenyl 
diphosphate (IPP) isomerase, could be responsible for DMAPP supply (Berthelot, et al., 2012). 
NzsE is a putative acyl carrier protein (ACP), which presumably transfers malonyl-CoA into 
malonyl-ACP. Both  NzsF and NzsJ are annotated as putative 3-oxoacyl-ACP synthases (KASIII). 
However, they share no significant sequence similarity with each other. While NzsJ bears no 
significant homology to characterized KAS III proteins, NzsF shares moderate sequence 
identity (37% identity and 55% similarity) to FabH from Streptomyces coelicolor A3(2) (Revill, 
et al., 2001), which catalyses the condensation reaction between acetyl-CoA and malonyl-ACP 
to form acetoacetyl-ACP. It is postulated that NzsF is responsible for the formation of 
acetoacetyl-ACP using acetyl-CoA and malonyl-ACP as substrates, followed by reduction to 
generate 3-hydroxy butyryl-ACP. 
We propose that NzsH could perform an acyloin coupling reaction between indole 3-pyruvate 
and pyruvate to generate α-ketoacid intermediate 7. The condensation reaction between 7 
and 3-hydroxy-butyryl-ACP could be mediated by the putative KASIII enzyme NzsJ via a 
reversible indole attack to yield 8. Decarboxylation-driven cyclization of 8 would result in an 
indol-fused cyclopentane intermediate 9, which could immediately undergo the ring 
rearrangement to generate an indol-fused cyclohexanone tricyclic intermediate 10, followed 
by dehydration and hydroxylation at C4 of 10, to generate 11. 11 would be readily 
tautomerized using positively-charged nitrogen in the indole ring as the electron sink, 
followed by dehydration via base-catalyzed double-bond migration to furnish the ortho-
quinone[b]indole tricyclic carbon backbone 12. Examination of the metabolite profile 
extracted from the culture of the ΔnzsG mutant allowed identification of an ion with the 
identical m/z to 12 (Figure S6). Although this compound could not be isolated, the mass is 
consistent with the structure of the predicted intermediate 12. The enzyme(s) responsible for 
the formation of 12 remain to be confirmed. The formation of 12 may partially resemble the 
enzymatic reaction catalysed by ScyC in the pathway of scytonemin (Balskus et al., 2009). The 
dimeric alkaloid scytonemin is a cyanobacterial metabolite, functioning as a sunscreen 
(Balskus et al., 2008). In case of scytonemin biosynthesis , ScyA, a ThDP-dependent enzyme, 
was found to be responsible for the acyloin coupling of indol-3-pyruvate and p-
hydroxyphenylpyruvate to yield the β-ketoacid product (Balskus et al., 2008), which can then 
be cyclized and decarboxylated by the action of the unique enzyme, ScyC, to form the indole-
fused cyclopentane intermediate (Balskus et al., 2009). It is hypothesized that NzsI could play 
a key role in this multistep biotransformation as our in vivo results indicated that nzsI is 
essential for the production of 1. The exact roles of NzsH, J and I in the biosynthesis of 1 is 
currently under investigation in our labs. 12 could further undergo reduction, followed by O-
methylation to yield the intermediate 5 and the shunt product streptovertillicin 4. The 
prenylation event on 5 occurs in the presence of NzsG and DMAPP to produce 2. The 
hydroxylation of 2 by NzsA finally provides 1. Our in vivo and in vitro results unambiguously 
demonstrated the enzymatic coupled reactions from 5 to 1, where the prenylation catalysed 
by NzsG must occur prior to the NzsA-mediated hydroxylation (Figures 4 and 5). When nzsA 
is inactivated, the ΔnzsA mutant also accumulates the epoxylated metabolite 6 via an 
unidentified epoxidase. 
Significance 
Neocarazostatin A 1 is a potent free scavenging agent for protecting cell damage caused by 
free radicals. It possesses an intriguing tricyclic aromatic ring system, of which the chemical 
logic during the biosynthesis remains to be determined. We describe here the identification 
and characterization of the gene cluster for NZS biosynthesis in the soil bacterium 
Streptomyces sp. MA37 through in silico analysis, gene inactivation and complementation. 
Biochemical assays of NzsG revealed that it is a new PSL-type carbazole prenyltransferase for 
NZS biosynthesis. In vitro assays confirmed that NzsA is responsible for the installation of a 
hydroxyl group at 2 to generate 1. Finally we reconstituted the last two reactions tailoring the 
NZS biosynthesis and demonstrated the sequential enzymatic reaction catalysed by NszG, 
followed by NzsA to transform the key intermediate 5 to 1. 
Materials and Methods 
Media and strains used in this study 
E. coli DH10B and E. coli ET12567 (pUZ802) were cultured in LB or LA medium at 37 ºC. 
Streptomyces sp. MA37 was cultured in ISP2 medium (yeast extract 4 g/L, glucose 4 g/L, malt 
extract 10 g/L, pH 7.2), and modified ISP4 medium (10 g/L soluble starch, 2 g/L (NH4)2SO4, 1 
g/L K2HPO4, 1 g/L MgSO4·7H2O, 1 g/L NaCl, 1 g/L tryptone, 0.5 g/L yeast extract, 1 g/L peptone, 
trace element solution (1 mL/L), adjust pH to 7.2 before sterilization) containing the final 
concentration of 30 mM Mg2+ was used for conjugation of Streptomyces sp. MA37. 
DNA sequencing and analysis 
The open reading frames (ORFs) of the nzs gene cluster were deduced from the sequence by 
performing FramePlot 4.0 beta program (http://nocardia.nih.go.jp/fp4/). The corresponding 
deduced proteins were compared with other known proteins in the databases using the Basic 
Local Alignment Search Tool (BLAST) (http://www.ncbi.nlm.nih.gov/blast/). Amino acid 
sequence alignments were performed with the CLUSTALW algorithm from 
BIOLOGYWORKBENCH 3.2 software (http://workbench.sdsc.edu). The phylogenetic tree was 
drawn using MEGA 6.0 (Tamura., et al. 2013). The sequence of the neocarazostatin 
biosynthetic gene cluster was identified from the sequenced genome via BLAST method using 
YerE as the sequence query. The neocarazostatins biosynthetic gene cluster was submitted 
to NCBI GenBank with the accession number KP657980. 
Extraction and purification of neocarazostatin A, neocarazostatin B, (R)-streptoverticillin, 
precarazostatin and 16, 17-epoxyneocarazostatin B.  
Streptomyces sp. MA37 and its mutants were inoculated into ISP2 medium, and were grown 
for two days at 28°C, 200 rpm. Then the culture was transferred into fresh ISP2 medium 
(1:100, volume to volume) and cultivated at 28°C, 200 rpm for 5 days. Mycelia were collected 
and re-suspended in one-tenth of the original culture volume of acetone, and the suspension 
was ultrasonically disrupted using KQ3200V Ultrasonic cleaning apparatus (40 kHz, 25 min). 
Cell pellets were eliminated by centrifugation and supernatant were subsequently dried out 
by rotary evaporation. Meanwhile the culture supernatant was extracted by an equal volume 
of ethyl acetate twice. The organic phase was collected and evaporated to dryness. Residues 
from two extracts were combined and re-dissolved in 1/100 of original culture volume of 
methanol for HPLC or LC-MS detection. Purification of the target compounds was performed 
by gel filtration (Sephadex G200) using methanol as the mobile phase. The corresponding 
sections were dried by rotary evaporation and dissolved in methanol, and were further 
purified by semi-preparative HPLC on an Agilent ZORBAX SB-C18 column (5 mm, 9.4x250 mm) 
at a flow rate of 3 mL/min. The wavelength of the UV monitor was set at 247 nm. For the 
detection of neocarazostatin A, the mobile phase was 52:48 A/B (solvent A was 0.1% formic 
acid in ultrapure water and solvent B was 0.1% formic acid in CH3CN); for neocarazostatin B, 
the mobile phase was 42:58 A/B; for (R)-streptoverticillin, the mobile phase was 45:55 A/B; 
for precarazostatin the mobile phase was 53:47 A/B; and for 16,17-epoxy-neocarazostatin B 
the mobile phase was 53:47 A/B. Finally, 10 mg of neocarazostatin A 1 ([α]19D -29 (c 0.07, 
MeOH)), 8.5 mg of neocarazostatin B 2 ([α]30D -28.8 (c 0.055, MeOH)), 7 mg of (R)-
streptoverticillin 4 ([α]30D  -18.4 (c 0.84 MeOH)), and 4.3 mg of precarazostatin 5 [α]31D -18.5 (c 
0.07 MeOH), 4.5 mg of 16,17-epoxy-neocarazostatin B 6 ([α]30D -30.5 (c 0.34，MeOH)) were 
obtained. 
HPLC MS/MS analysis 
HPLC analysis was carried out on a DIKMA Diamonsil C18 column (250×4.6 mm, 5 µm, column 
temperature 30°C) using a DIOEX P680 HPLC instrument. For fermentation analysis, samples 
were eluted with a gradient from 90:10 A/B to 60:40 A/B over 10 min, followed by another 
gradient to 45:55 A/B over 35 min at a flow rate of 1 mL/min, and UV monitor detected at 
247 nm. For enzymatic analysis，samples were eluted with a gradient from 70:30 A/B to 
0:100 A/B over 18 min, at a flow rate of 1 mL/min, and UV monitored at 247 nm. For carbazole, 
fluorene, phenazine, dibenzothiophene, acridine, Trp, IAA, IBA and indole-3-pyruvic acid, 
samples were eluted with a gradient from 95:5 A/B to 0:100 A/B over 25 min, at a flow rate 
of 1 mL/min, and UV monitored at 220 nm for carbazole, fluorene, phenazine, 
dibenzothiophene, 392 nm for acridine and 280 nm for Trp, IAA, IBA and indole-3-pyruvic 
acid. Twenty percent of the eluent was injected to source and eighty percent to waste during 
LC-MS analysis. Solvent A was 0.1% formic acid in ultrapure water and solvent B was 0.1% 
formic acid in CH3CN. The same column and LC gradient was used in all LC-MS analysis. High 
resolution MS analysis, which consisted of a full scan in positive mode followed by a data 
dependent fragmentation scan, was performed on a Thermo Scientific LTQ XL Orbitrap mass 
spectrometer equipped with a Thermo Scientific Accela 600 pump. 
NMR analysis 
Nuclear magnetic resonance spectra of neocarazostatin B 2 (8.5 mg), (R)-streptoverticillin 4 (7 
mg), precarazostatin 5 (4.3 mg), and 16,17-epoxyneocarazostatin B 6 were recorded on Agilent 600 
MHz instrument in CD3OD. Nuclear magnetic resonance analyses of neocarazostatin A 1 were 
recorded on Varian 600 MHz spectrometer in CD3Cl. 
Structural elucidation of neocarazostatin A 1 
HRESIMS analysis of 1 established a molecular formula of C22H27NO4. Dereplication using 
Antibase (Laatsch, 2013) suggested that this compound could be a known metabolite, 
neocarazostatin A, previously isolated from Streptomyces sp. GP38 (Kata, et al., 1991).  1 also 
showed a characteristic UV pattern, with absorption maxima at 229, 249, 271, 292, 331 and 
345 nm. To confirm the structure, a complete set of 1D and 2D NMR spectral data was 
obtained. The structure of 1 was finally established through comparison of 1H and 13C NMR 
spectra data with those previously reported which unambiguously confirms that 1 is 
neocarazostatin A. 
In-frame deletion of nzsA to nzsH 
To inactivate nzsA, a 2030 bp upstream fragment and a 2002 bp downstream fragment were 
amplified from genomic DNA of Streptomyces sp. MA37 by PCR using the primers N-2-up-F/N-
2-up-R and N-2-do-F/N-2-do-R respectively (Table S3). PCR was performed in 20 µL volume 
with 5% DMSO and KOD DNA polymerase (TOYOBO). The amplification conditions were: initial 
denaturation at 95 °C for 5 min; 30 cycles of denaturation at 95 °C for 30 s, annealing at 58 °C 
for 30 s, and extension at 68 °C for 2 min; and gap infilling at 68°C for 10 min. The obtained 
fragments were cloned into the HindIII/EcoRI site of pKC1139 by using In-fusion○R HD Cloning 
Kit (Clontech) to obtain the in-frame deletion vector construct, which was then transferred 
into Streptomyces sp. MA37 via E. coli-Streptomyces conjugation. Following a previously-
published procedure (Yu et al., 2009), the nzsA in-frame deletion mutant strains were 
identified by screening out and designated as WDY633. The same strategy was used to 
construct nzsB to nzsJ in-frame deletion mutants, except that different primers were used to 
amplify the left and right arms of the target genes (Table S3). The in-frame deletion mutant 
strains of nzsB to NzsJ were designated as WDY640, WDY641, WDY642, WDY644, WDY646, 
WDY638, WDY630, WDY648, and WDY635 respectively (Table S1). 
Complementation of the mutant strain WDY633, WDY644, WDY646, WDY638, WDY630, 
WDY648 and WDY635 
To complement WDY633, a 1257 bp fragment that contains the whole nzsA gene sequence 
was amplified from genomic DNA of Streptomyces sp. MA37 by high fidelity PCR using the 
primers N-1-HB-F/N-1-HB-R (Table S3). The amplification conditions were: initial denaturation 
at 95 °C for 5 min; 30 cycles of denaturation at 95 °C for 30 s, annealing at 58 °C for 30 s, and 
extension at 68 °C for 1 min; and gap infilling at 68°C for 10 min. The obtained fragment was 
cloned into the NdeI/EcoRI site of pIB139, which can integrate into Streptomyces 
chromosome via ФC31 phage site. The construct obtained was then transferred into 
Streptomyces sp. MA37 in-frame deletion mutant via E. coli-Streptomyces conjugation. 
Followed the procedure described previously (Kieser et al., 2000), the ΔnzsA 
complementation mutant strain was identified by screening out and designated as WDY634. 
The same strategy was used to complement WDY644, WDY646, WDY638, WDY630, WDY648, 
and WDY635, except that different pairs of primers were used for each complementation 
construct (Table S3). The complementation mutant strains of ΔnzsB, ΔnzsE, ΔnzsF and ΔnzsG-
J were identified by screening out and designated as WDY638, WDY647, WDY639, WDY631, 
WDY649 and WDY636 respectively. 
Construction of NzsA and NzsG overexpression vector 
To overexpress NzsA, a 1257 bp fragment that contains the whole nzsA was amplified from 
genomic DNA of Streptomyces sp. MA37 by PCR using the primers NzsA_F/NzsA _R (Table S3). 
PCR was performed in 20 µL volume with 5% DMSO and KOD DNA polymerase (TOYOBO). The 
amplification conditions were: initial denaturation at 95 °C for 5 min; 30 cycles of 
denaturation at 95 °C for 30 s, annealing at 58 °C for 30 s, and extension at 68 °C for 90 s; and 
gap infilling at 68°C for 10 min. The obtained fragments were cloned into the KpnI/XhoI site 
of pHS_SUMO (Lv, et al., 2015) by using In-fusion HD Cloning Kit (Clontech) to yield the 
overexpression construct pWDY651. The same strategy was used for nzsG cloning, except that 
the primers NzsG_F/NzsG_R were used for amplification (Table S3). The NzsG overexpression 
construct was designated pWDY650. 
Expression and purification of NzsA and NzsG 
The protein expression constructs pWDY638 and pWDY639 were individually transformed 
into E. coli BL21 (lDE3) (Novagen) competent cells. Single colonies from each transformation 
were inoculated to a starter culture (5 mL SOB media containing 50 µg/mL kanamycin) and 
cultivated at 37 °C and 200 rpm. When the A600 of the medium reached 0.5, the culture was 
transferred to 500 mL of fresh SOB medium and incubated at 37 °C, 200 rpm. IPTG was added 
to a final concentration of 1 mM when the A600 reached 0.6. After overnight culture at 16 °C, 
cells were harvested by centrifugation and frozen at −40 °C. All subsequent steps were 
performed at 4 °C. After thawed on ice, cells were suspended in lysis buffer (200 mM Tris-HCl, 
pH 8.0, 500 mM NaCl, 10 mM imidazole). The cell suspension was lysed with a Nano 
Homogenize Machine (ATS Engineering Inc, AH100B). To separate the cellular debris from the 
soluble protein, the lysate was centrifuged at 20,000 x g, 4 °C for 20 min. The supernatant was 
incubated with 1.5 mL Ni SepharoseTM 6 Fast Flow (GE Healthcare) which had been pre-
equilibrated with equilibration buffer (200 mM Tris-HCl (pH 8.0), 500 mM NaCl, and 10 mM 
imidazole) for 2 h at 4 °C. The resin was washed with 5 mL of the equilibration buffer, followed 
by then twice with buffer containing 25 mM imidazole. The recombinant protein was eluted 
with 5 mL wash buffer containing 250 mM imidazole. The eluted recombinant proteins were 
concentrated to 2.5 mL using Centrifugal Filter Units (Milipore, Regenerated Cellulose 3,000 
MWCO). Then the samples were desalted by PD-10 Columns (GE Healthcare) according to 
manufacture instruction. The cleavage of the SUMO tag of the eluted recombinant proteins 
was conducted by using SUMO Protease (Invitrogen, Catalog no. 12588-018) in the buffer 
composed of 50 mM Tris-HCl, pH 8.0, and 150 mM NaCl at 4 °C for 4 h. The SUMO tag and 
SUMO Protease were finally removed from the cleavage reaction by using 0.5 mL Ni 
SepharoseTM 6 Fast Flow (GE Healthcare). The purified protein was stored at -80 °C in storage 
buffer (50mM Tris-HCl, pH 8.0, 150mM NaCl, 10% (w/v) glycerol, 1mM DTT). 
NzsG activity assay 
The enzyme assay of NzsG was carried out in 50 mM Tris-HCl buffer (pH 7.5) with 5 mM MgCl2, 
containing 0.8 mg/mL NzsG, 1 mM substrate and 0.2 mM DMAPP, in a final volume of 50 µL. 
The optimal assay conditions were obtained at 30 °C. After 30 min, the reaction was quenched 
by the addition of two equal volume of methanol and mixed by vortexing. The mixture was 
centrifuged at 15,000 rpm for 20 min to remove protein. The supernatant was then subjected 
to LC-MS/MS analysis under the same conditions as described above.  
Kinetic studies of NzsG 
Optimization of NzsG in vitro assays is described in the Figure S4D legend. The enzyme assays 
of NzsG were performed in a total volume of 50 μL mixture containing 50 mM Tris-HCl (pH 
8.0), 5 mM Mg2+, 1 mM DMAPP, 1 mM DTT and 0.087 mM to 3 mM precarazostatin 5 at 30 °C 
for 10 min. Reactions were initiated by the addition of enzyme (0.5 μM NzsG). An equal 
volume of methanol to quench the reaction and to remove proteins by centrifugation. The 
supernatant was analyzed by HPLC. Kinetic analyses of NzsG reactions were carried out as 
described in the Figure S4F legend 
NzsA activity assay 
Enzyme assay of NzsA activity was carried out on a 50 µL scale with substrates (1 mM), NzsA 
(1mg/mL), spinach ferredoxin (100 µg/mL), spinach ferredoxin-NADP+ reductase (0.2 U/mL), 
NADPH (1.0 mM), glucose-6-phosphate (10 mM), and glucose-6-phosphate dehydrogenase 
(10 U/mL) in Tris-HCl buffer (50 mM, pH 7.5). After incubated at 30 °C for 30 min, the reaction 
was quenched by the addition of two equal volume of methanol and mixed by vortexing. The 
mixture was centrifuged at 15,000 rpm for 20 min to remove protein. The supernatant was 
then subjected to LC-MS/MS analysis under the same conditions as described above. 
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Figure 1. Chemical structures of common tricyclic carbazole alkaloids from bacteria 
 
  
Figure 2 A. Genetic organization of the nzs biosynthetic gene cluster. Blue: the genes 
putatively involved in the biosynthesis of 1. Red: genes involved in the biosynthesis of indole-
3-pyruvate precursor; Yellow: genes involved in the biosynthesis of DMAPP precursor; Purple: 
genes putatively involved in the PKS biosynthesis; Grey: gene with unknown function. B. HPLC 
analyses (UV at 247nm) of extracts from the Streptomyces sp. MA37 wild type and mutant 
strains. 1 and 10: wild type strain; 2: WDY633 (ΔnzsA mutant); 3: WDY634 (ΔnzsA 
complementation mutant); 4: WDY638 (ΔnzsG mutant); 5: WDY639 (ΔnzsG complementation 
mutant); 6: WDY640 (ΔnzsB mutant); 7: WDY641 (ΔnzsC mutant); 8: WDY642 (ΔnzsD mutant); 
9: WDY644 (ΔnzsE mutant); 11: WDY645 (ΔnzsE complementation mutant); 12: WDY646 
(ΔnzsF mutant); 13: WDY647 (ΔnzsF complementation mutant); 14: WDY630 (ΔnzsH mutant); 
15: WDY631 (ΔnzsH complementation mutant); 16: WDY648 (ΔnzsI mutant); 17: WDY649 
(ΔnzsI complementation mutant); 18: WDY635 (ΔnzsJ mutant); 19: WDY636 (ΔnzsJ 
complementation mutant). 
 
Table 1. Deduced functions of ORFs in nzs biosynthetic gene cluster 
 
  
Figure 3. Chemical structures of intermediates and shunt products isolated from the 
mutants in this study. The structures of 2, 4-6 were fully characterized by HR-ESIMS 




Figure 4. HPLC analysis (UV at 247 nm) of the reactions catalysed by NzsG. Trace A. 
standard 5; Trace B shows the analysis of the conversion of 5 to 2 in a reaction 
containing Mg2+ (5mM), 5 (1mM), NzsG (0.8 mg/mL) and DMAPP (0.2 mM); Traces C-F 
show the analyses of reactions containing Mg2+(5 mM), NzsG (0.8 mg/mL) and various 
substrates, indicating that only 5 is the substrate for NzsG. 
 
 
Figure 5. HPLC analysis (UV at 247 nm) of the biochemical reactions in presence of NzsA. Trace 
A shows the analysis of the conversion of 2 to 1 in a reaction containing 2 (1 mM), NzsA 
(1mg/mL), spinach ferredoxin (100 µg/mL), spinach ferredoxin-NADP+ reductase (0.2 U/mL), 
NADPH (1.0 mM), glucose-6-phosphate (10 mM), and glucose-6-phosphate dehydrogenase 
(10 U/mL) in a Tris-HCl buffer (50 mM, pH 7.5). Trace B shows the standard 2; Traces C-E show 
the analyses of reactions containing NADPH, NzsA (1 mg/mL) and various substrates, 






Scheme 1 A. Proposed model for indole-3-pyruvate; B. the biosynthesis of DMAPP; C. the 
biosynthesis of 3-hydroxy-butyryl-ACP; D. Proposed biosynthetic pathway of 1. Bracket: 9 was 
observed to be present in the extract of the mutant nzsG based on HR-ESIMS and MSn 
analyses. Dashed line: proposed reactions. Solid line: reactions were confirmed biochemically. 
 
 
